Indoco Remedies shares slide after USFDA issues seven Goa plant observations
Indoco Remedies’ shares fell as much as 5.5% on Sept. 7 after the US Food and Drug Administration issued seven observations following an inspection of its Plant II (Sterile) facility in Goa.
Shares of Indoco Remedies Ltd. 5% on Monday, September 7, after the US Food and Drug Administration (USFDA) issued 7 observations to the company following an inspection of its manufacturing facility in Goa. The USFDA inspected the company’s Plant II (Sterile) facility in Goa.